85 related articles for article (PubMed ID: 22798506)
1. Increased serum level of RPMPS-1/S27 protein in patients with various types of cancer is useful for the early detection, prevention and therapy.
Fernandez-Pol JA
Cancer Genomics Proteomics; 2012; 9(4):203-56. PubMed ID: 22798506
[TBL] [Abstract][Full Text] [Related]
2. Conservation of multifunctional ribosomal protein metallopanstimulin-1 (RPS27) through complex evolution demonstrates its key role in growth regulation in Archaea, eukaryotic cells, DNA repair, translation and viral replication.
Fernandez-Pol JA
Cancer Genomics Proteomics; 2011; 8(3):105-26. PubMed ID: 21518817
[TBL] [Abstract][Full Text] [Related]
3. Metallopanstimulin as a novel tumor marker in sera of patients with various types of common cancers: implications for prevention and therapy.
Fernandez-Pol JA
Anticancer Res; 1996; 16(4B):2177-85. PubMed ID: 8694540
[TBL] [Abstract][Full Text] [Related]
4. Expression of metallopanstimulin and oncogenesis in human prostatic carcinoma.
Fernandez-Pol JA; Fletcher JW; Hamilton PD; Klos DJ
Anticancer Res; 1997; 17(3A):1519-30. PubMed ID: 9179190
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of metallopanstimulin/S27 ribosomal protein in hepatic regeneration and neoplasia.
Ganger DR; Hamilton PD; Klos DJ; Jakate S; McChesney L; Fernandez-Pol JA
Cancer Detect Prev; 2001; 25(3):231-6. PubMed ID: 11425264
[TBL] [Abstract][Full Text] [Related]
6. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
Bremnes RM; Sirera R; Camps C
Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
9. CEA in activated macrophages. New diagnostic possibilities for tumor markers in early colorectal cancer.
Japink D; Leers MP; Sosef MN; Nap M
Anticancer Res; 2009 Aug; 29(8):3245-51. PubMed ID: 19661342
[TBL] [Abstract][Full Text] [Related]
10. [Expression and clinical significance of cancer-related gene MPS-1 in gastric cancer].
Wang YW; Zhu ZG; Liu BY; Gu QL; Li JF; Qu Y; Chen XH; Lin YZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):503-6. PubMed ID: 16299651
[TBL] [Abstract][Full Text] [Related]
11. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer.
Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810
[TBL] [Abstract][Full Text] [Related]
12. Metallopanstimulin / S27 Ribosomal Antigen Expression in Stages I and II Breast Cancer: its Relationship with Clinicopathologic Factors.
Sundblad AS; Ricci L; Xynos FP; Fernandez-Pol JA
Cancer Genomics Proteomics; 2005; 2(1):53-60. PubMed ID: 31394666
[TBL] [Abstract][Full Text] [Related]
13. Metallopanstimulin is overexpressed in a patient with colonic carcinoma.
Ganger DR; Hamilton PD; Fletcher JW; Fernandez-Pol JA
Anticancer Res; 1997; 17(3C):1993-9. PubMed ID: 9216656
[TBL] [Abstract][Full Text] [Related]
14. Genomics, Proteomics and Cancer: Specific Ribosomal, Mitochondrial, and Tumor Reactive Proteins Can Be Used as Biomarkers for Early Detection of Breast Cancer in Serum.
Fernandez-Pol JA; Hamilton PD; Klos DJ
Cancer Genomics Proteomics; 2005; 2(1):1-24. PubMed ID: 31394662
[TBL] [Abstract][Full Text] [Related]
15. Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer.
Friel AM; Corcoran C; Crown J; O'Driscoll L
Breast Cancer Res Treat; 2010 Oct; 123(3):613-25. PubMed ID: 20549336
[TBL] [Abstract][Full Text] [Related]
16. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
17. Detection of melanoma relapse: first comparative analysis on imaging techniques versus S100 protein.
Beyeler M; Waldispuhl S; Strobel K; Joller-Jemelka HI; Burg G; Dummer R
Dermatology; 2006; 213(3):187-91. PubMed ID: 17033166
[TBL] [Abstract][Full Text] [Related]
18. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
Ellinger J; Albers P; Perabo FG; Müller SC; von Ruecker A; Bastian PJ
J Urol; 2009 Jul; 182(1):324-9. PubMed ID: 19447423
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of tumor markers and evaluation of their predictive value in patients with colorectal cancer.
Liu ZP; Li LM; Liu XL; Zhang DX
Onkologie; 2012; 35(3):108-13. PubMed ID: 22414974
[TBL] [Abstract][Full Text] [Related]
20. [Expression of Cdc7 and mcm2 as a marker for proliferation and prognosis in diffuse large B cell lymphoma].
Hou Y; Wang HQ; Fu K; Zhang HL; Qian ZZ; Qiu LH; Li W; Zhou SY; Li LF; Hao XS
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):911-5. PubMed ID: 22340100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
